STAAR SURGICAL CO — Director's Dealing 2021

Nov 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-11-16

Reporting Person: Mason Caren L (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-16	Common Stock	M	35000	$7.76	Acquired	98376	Direct
2021-11-16	Common Stock	S	35000	$114.20	Disposed	63376	Direct
2021-11-17	Common Stock	M	35000	$7.76	Acquired	98376	Direct
2021-11-17	Common Stock	S	35000	$113.83	Disposed	63376	Direct
2021-11-18	Common Stock	M	35000	$7.76	Acquired	98376	Direct
2021-11-18	Common Stock	S	35000	$113.83	Disposed	63376	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-16	Common Stock Options	$7.76	M	35000	Disposed	2025-03-02	Common Stock (35000)	Direct
2021-11-17	Common Stock Options	$7.76	M	35000	Disposed	2025-03-02	Common Stock (35000)	Direct
2021-11-18	Common Stock Options	$7.76	M	35000	Disposed	2025-03-02	Common Stock (35000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.32 to $115.62.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.72 to $115.93.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.06 to $114.06.